Skip to main content

A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma.

Publication ,  Conference
Rich, JN; Reardon, DA; Quinn, JA; Vredenburgh, JJ; Desjardins, A; Sathornsumetee, S; Gururangan, S; Lyons, P; Bigner, DD; Friedman, HS
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005

Duke Scholars

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

130S / 130S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rich, J. N., Reardon, D. A., Quinn, J. A., Vredenburgh, J. J., Desjardins, A., Sathornsumetee, S., … Friedman, H. S. (2005). A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 130S-130S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Rich, J. N., D. A. Reardon, J. A. Quinn, J. J. Vredenburgh, A. Desjardins, S. Sathornsumetee, S. Gururangan, P. Lyons, D. D. Bigner, and H. S. Friedman. “A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma.” In JOURNAL OF CLINICAL ONCOLOGY, 23:130S-130S. AMER SOC CLINICAL ONCOLOGY, 2005.
Rich JN, Reardon DA, Quinn JA, Vredenburgh JJ, Desjardins A, Sathornsumetee S, et al. A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 130S-130S.
Rich, J. N., et al. “A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma.JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 130S-130S.
Rich JN, Reardon DA, Quinn JA, Vredenburgh JJ, Desjardins A, Sathornsumetee S, Gururangan S, Lyons P, Bigner DD, Friedman HS. A phase I trial of gefitinib (ZD1 839) plus rapamycin for patients with recurrent malignant glioma. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 130S-130S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

130S / 130S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences